Displaying 121 - 140 of 203 results

Scientific Director of Intramural Research, Dr. John O'Shea, Elected to the U.S. National Academy of Sciences

https://www.niams.nih.gov/newsroom/announcements/scientific-director-intramural-research-dr-john-oshea-elected-us-national

On May 2, 2023, NIAMS Scientific Director of Intramural Research, Dr. John O’Shea, was elected to the U.S. National Academy of Sciences at the conclusion of the Academy’s 160 th annual meeting. This designation – considered one of the highest honors that a scientist can achieve – recognizes distinguished and continuing achievements in original research. In addition to this latest accolade, Dr. O’Shea has received numerous prizes, including the Howley Prize for Research in Arthritis, the Ross Prize in Molecular Medicine, the Millstein Prize from the International Cytokine and Interferon Society, the AAI-Steinman Award for Human Immunology, the ASCI-Harrington Prize

Living With Back Pain: Health Information Basics for You and Your Family

https://www.niams.nih.gov/community-outreach-initiative/understanding-muscle-health/living-with-back-pain

Back pain is one of the most common medical problems in the United States. Changes to any part of your back—such as ones that may occur with aging, getting hurt, or having other medical conditions—can lead to back pain. It can start suddenly or come on slowly. It may feel like a dull, constant ache, or a sudden, sharp pain.

The NIAMS Training Program (T32)

https://www.niams.nih.gov/grants-funding/research-training-and-career-development-programs/funding-opportunities/t32_program

Goal of NIAMS Institutional Training Awards NIAMS funds the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) (PA-23-048) to enable institutions to support pre-doctoral and postdoctoral research training for individuals in the fields of arthritis and musculoskeletal and skin diseases. The NIAMS T32 program's primary

Exploratory Clinical Trial Grants (R61)

https://www.niams.nih.gov/grants-funding/conducting-clinical-research/exploratory-grants

The Exploratory Clinical Trial Grant Program fosters the development and implementation of interventional exploratory clinical trials aimed at providing clinically meaningful improvements in symptoms, function or disease course for patients with rheumatic, musculoskeletal or skin diseases. The trials must address research questions related to the mission and goals of the

Colbert Selected to Lead NIAMS Clinical Research Program

https://www.niams.nih.gov/newsroom/announcements/colbert-selected-lead-niams-clinical-research-program

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) appointed Robert A. Colbert, M.D., Ph.D., as the director of the Institute's Clinical Research Program on February 16, 2020. Colbert, who joined the NIAMS in 2008, had served as deputy clinical director since 2012 and as acting clinical director since June 2018. "What excites me about the NIAMS Clinical Research Program director position is the opportunity we have to make an impact," Colbert explained. "We have a number of research programs that are making new discoveries that reveal how diseases develop and evolve and are translating these discoveries into

Hairy human skin generated from stem cells

https://www.niams.nih.gov/hairy-human-skin-generated-stem-cells

Skin is the body’s largest organ and plays a vital role in health. It helps regulate body temperature, retain body fluid, and defend against the outside world. It also allows the sensation of touch and pain. Skin is a complex structure made up of multiple layers. It contains fat, nerves, glands, and hair follicles. Scientists have been able to grow human skin outside the body for over 40 years. However, skin grown in cultures lacked embedded structures, like hair follicles and sweat glands, found in real skin. A team of researchers led by Dr. Karl Koehler of Boston Children’s Hospital

Typically materials from NIAMS that are more than 5 years old will be archived.